EAM Investors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-207,152
| Closed | -$4.89M | – | 349 |
|
|
2023
Q4 | $4.89M | Sell |
207,152
-174,412
| -46% | -$4.12M | 0.87% | 7 |
|
|
2023
Q3 | $5.69M | Buy |
381,564
+8,940
| +2% | +$133K | 1.1% | 2 |
|
|
2023
Q2 | $4.08M | Buy |
372,624
+56,030
| +18% | +$614K | 0.76% | 13 |
|
|
2023
Q1 | $2.76M | Sell |
316,594
-233,876
| -42% | -$2.04M | 0.54% | 53 |
|
|
2022
Q4 | $3.45M | Buy |
550,470
+210,692
| +62% | +$1.32M | 0.71% | 18 |
|
|
2022
Q3 | $1.19M | Buy |
+339,778
| New | +$1.19M | 0.26% | 171 |
|
|
2020
Q4 | – | Sell |
-354,337
| Closed | -$2.57M | – | 412 |
|
|
2020
Q3 | $2.57M | Buy |
+354,337
| New | +$2.57M | 0.61% | 33 |
|
|
2018
Q3 | – | Sell |
-96,188
| Closed | -$1.29M | – | 385 |
|
|
2018
Q2 | $1.29M | Sell |
96,188
-237,549
| -71% | -$3.19M | 0.2% | 177 |
|
|
2018
Q1 | $4.34M | Sell |
333,737
-100,076
| -23% | -$1.3M | 0.72% | 15 |
|
|
2017
Q4 | $3.99M | Sell |
433,813
-160,191
| -27% | -$1.47M | 0.71% | 14 |
|
|
2017
Q3 | $4.79M | Buy |
+594,004
| New | +$4.79M | 0.64% | 32 |
|